Asthma is a disease of the lungs that affects people of all ages and both sexes. About 1 in 13 people in the United States ...

A mom in Minnesota is heading to prison for causing the death of her daughter after she refused to let the parents of one of ...

Company has also raised $12 million in funding led by Lucius Partners NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- AerWave Medical, a leader in ultrasound-based interventional pulmonary solutions, ...

A recent study published in The Journal of Allergy and Clinical Immunology: In Practice found that gestational diabetes ...

Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca ... Asthma & Immunology, and medical director of Capital Allergy & Respiratory Disease Center in Sacramento, California ...

Research using nasal swabs to identify asthma subtypes promises precise treatment. T2-high asthma may be less common than T2-low, suggesting a need for new treatments. Meanwhile, insights into why ...

An allergic reaction in babies can range from mild to life-threatening. Here’s how to tell if your child is having an ...

NHS Sussex is urging parents, carers, teachers, and healthcare professionals to take proactive steps in managing childhood asthma this January.

For example, knowing that 40% of the children with atopic dermatitis will subsequently develop asthma, the Early Treatment of Atopic Child (ETAC) study was a randomized controlled trial of ...

London: GSK plc has announced that the China National Medical Products Administration has approved Nucala (mepolizumab), a ...

The China NMPA has approved GSK’s Nucala (mepolizumab) as an add-on treatment along with intranasal corticosteroids to treat CRSwNP.

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...